Acotec Scientific (HKG:6669) has obtained registration approval for the Paclitaxel-Eluting Coronary Balloon Dilatation Catheter AcoArt Camellia from China's National Medical Products Administration, a Tuesday bourse filing said.
The product is indicated for the treatment of de novo coronary artery lesions, according to the medical equipment maker.